Clinical Trial Update: Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the safety and immunogenicity of co-administering the 23-valent pneumococcal polysaccharide vaccine with an influenza vaccine in child…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• Influenza vaccine (influenza vaccine)
• Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Pneumococcal Infection, Influenza | Phase 4 | Status: COMPLETED